Variant report
Variant | nsv1018154 |
---|---|
Chromosome Location | chr9:9938036-9951874 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs367904035 | chr9:9939404-9939405 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs190485785 | chr9:9939432-9939433 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs543780821 | chr9:9939468-9939469 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs182462558 | chr9:9939484-9939485 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs183506104 | chr9:9939492-9939493 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs564404334 | chr9:9939539-9939540 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs538559663 | chr9:9939549-9939550 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs188192678 | chr9:9939555-9939556 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs145851543 | chr9:9939614-9939615 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs149011589 | chr9:9939618-9939619 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs531425808 | chr9:9939623-9939624 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs548014951 | chr9:9939636-9939637 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs568240985 | chr9:9939649-9939650 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs533948898 | chr9:9939650-9939651 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs574274241 | chr9:9939656-9939657 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs554026256 | chr9:9939683-9939684 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs145513891 | chr9:9939685-9939686 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs527866283 | chr9:9939690-9939691 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs7859469 | chr9:9939693-9939694 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs556509123 | chr9:9939734-9939735 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs10978117 | chr9:9939737-9939738 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs528701883 | chr9:9939739-9939740 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs542285869 | chr9:9939764-9939765 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs7849423 | chr9:9939766-9939767 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
25 | rs181035402 | chr9:9939790-9939791 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs185654424 | chr9:9939798-9939799 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs539904186 | chr9:9942608-9942609 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs189776214 | chr9:9942617-9942618 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs576134968 | chr9:9942621-9942622 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs139341377 | chr9:9942625-9942626 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs79135932 | chr9:9942628-9942629 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs541981831 | chr9:9942638-9942639 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs182387958 | chr9:9942659-9942660 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs374702926 | chr9:9942661-9942662 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs75075829 | chr9:9942685-9942686 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs372207268 | chr9:9942693-9942694 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs560079907 | chr9:9942816-9942817 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs559007823 | chr9:9942834-9942835 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs569398126 | chr9:9942840-9942841 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs552172373 | chr9:9942881-9942882 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs538038290 | chr9:9942886-9942887 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs148080217 | chr9:9942892-9942893 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs77415397 | chr9:9942895-9942896 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs113089194 | chr9:9942896-9942897 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs368007306 | chr9:9942920-9942921 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs562398168 | chr9:9942937-9942938 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs78246825 | chr9:9942944-9942945 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs548395276 | chr9:9942947-9942948 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs541350520 | chr9:9942954-9942955 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs367572032 | chr9:9942956-9942957 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
abnormal development | 18461090 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Cancer | 20164920 | CNVD |
Lung cancer | 20668451 | CNVD |
Schizophrenia | 20838587 | CNVD |
Glioblastoma | 18772890 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 20858261 | CNVD |
Epilepsy | 20858261 | CNVD |
Mental retardation | 20858261 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Lung adenocarcinoma | 17982442 | CNVD |
Breast cancer | 21611746 | CNVD |
Schizophrenia | 23813976 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:9939400-9939800 | Enhancers | Pancreatic Islets | Pancreatic Islet |
2 | chr9:9942600-9943000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
3 | chr9:9942600-9943000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
4 | chr9:9943000-9943400 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
5 | chr9:9943200-9943600 | Enhancers | Fetal Heart | heart |
6 | chr9:9943400-9944400 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
7 | chr9:9943600-9944200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
8 | chr9:9943600-9949600 | Weak transcription | Fetal Heart | heart |
9 | chr9:9943800-9944400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
10 | chr9:9946400-9946800 | Enhancers | Fetal Brain Male | brain |
11 | chr9:9949600-9949800 | Active TSS | Fetal Heart | heart |
12 | chr9:9949600-9950400 | Enhancers | Pancreatic Islets | Pancreatic Islet |
13 | chr9:9949800-9950000 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
14 | chr9:9949800-9950400 | Flanking Active TSS | Fetal Heart | heart |
15 | chr9:9950000-9950400 | Enhancers | Left Ventricle | heart |
16 | chr9:9950000-9951400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
17 | chr9:9950000-9952400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
18 | chr9:9950400-9950800 | Enhancers | Fetal Heart | heart |
19 | chr9:9950800-9951200 | Flanking Active TSS | Fetal Heart | heart |
20 | chr9:9950800-9952600 | Enhancers | Primary hematopoietic stem cells | blood |
21 | chr9:9951200-9954200 | Enhancers | Fetal Heart | heart |
22 | chr9:9951400-9951800 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
23 | chr9:9951800-9952200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |